Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2003
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086466A1 Novel thrombomodulin expression promoters
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086444A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003WO2003086433A1 Therapeutic cream for dermatitis
10/23/2003WO2003086432A1 Therapeutic lotion for dermatitis
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086317A2 Protein a compositions and methods of use
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2002094248A3 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002069793A8 Extracorporeal blood processing information management system
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002042272A8 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/23/2003WO2001045641A8 Inhibitors of thrombin induced platelet aggregation
10/23/2003WO2001041754A8 Inhibitors of collagen-induced platelet aggregation
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders
10/23/2003US20030199689 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199573 2h-chromene derivatives metabolized both by cytochrome P450 and by a non-oxidative metabolic enzyme or system of enzymes; do not cause metabolic DDI when co-administered with other drugs
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199505 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations
10/23/2003US20030199504 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations
10/23/2003US20030199483 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of pathogenic conditions
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199476 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
10/23/2003US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199456 Sodium channel blockers
10/23/2003US20030199444 Comprising a preparation of Blood Factor VII or a Factor VII-related polypeptide and a preparation of factor VIII (antihemophilic factor) or a factor VIII-related polypeptide; high speed coagulants in one dosage form; kits; hemostatis
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199067 Growth arrest homeobox gene
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198691 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
10/23/2003US20030198690 Administering zinc using stent; antiproliferative agent
10/23/2003US20030198619 Mixture containing permeability intensifier; in situ gelation using nonionic surfactant
10/23/2003CA2482926A1 Modified factor viii
10/23/2003CA2482893A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003CA2482713A1 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481385A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2480883A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480365A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003CA2480331A1 Lotion for therapy of dermatitis
10/23/2003CA2480221A1 Cream for therapy of dermatitis
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354888A1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines
10/22/2003EP1354880A1 Halogen compounds having thrombopoietin receptor agonism
10/22/2003EP1354877A1 Hetero-tricyclic compounds having substituted amino groups
10/22/2003EP1354868A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof
10/22/2003EP1354603A1 Concomitant drugs
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354597A2 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1354032A2 Gene regulation therapy involving ferritin
10/22/2003EP1353954A2 Anticoagulants and their uses
10/22/2003EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
10/22/2003EP1353928A2 Process for preparing clopidogrel
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353906A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/22/2003EP1353896A2 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1194441B1 A2a receptor agonists
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450996A 2-guanidino-4-aryl-quinazoline
10/22/2003CN1450907A Beta glycan as an inhibin receptor and uses thereof
10/22/2003CN1450905A Method for improving the cell protection
10/22/2003CN1450901A The use of cocoa procyanidins combined with acetylsalic acid as an anti-platelet therapy
10/22/2003CN1450899A Bile secretion promoting composition
10/22/2003CN1450893A Method for treatment of sepsis
10/22/2003CN1450891A Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base
10/22/2003CN1450066A Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant
10/22/2003CN1449775A Medicine composition for preventing and treating thrombosis and relative disease
1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 671